Life Transitions

Latest News

FDA accepts BLA for Sandoz proposed denosumab biosimilar
FDA accepts BLA for Sandoz proposed denosumab biosimilar

February 6th 2023

The US Food and Drug Administration has accepted the Biologics License Application (BLA) for a proposed biosimilar of denosumab (Prolia and Xgeva; Amgen) for treatment of various conditions.

Elevated lifetime estrogen exposure could increase stroke risk in women
Elevated lifetime estrogen exposure could increase stroke risk in women

February 6th 2023

Can beverage choice increase urinary incontinence?
Can beverage choice increase urinary incontinence?

February 3rd 2023

Past traumas may worsen menopausal symptoms and wellbeing at midlife
Past traumas may worsen menopausal symptoms and wellbeing at midlife

October 19th 2022

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.